SCHEMBL9942704

SCHEMBL9942704

CC(C)(O)CNc1nc(-c2ccc(CF)cc2)cn2c(-c3ccc(C(=O)NC4CC4)cc3)cnc12

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9942224 0.93 TTK (0.69) TTK
SCHEMBL9936496 0.92 TTK (0.77) TTK
SCHEMBL9942341 0.91 TTK (0.73) TTK
SCHEMBL9942247 0.89 TTK (0.68) TTK
SCHEMBL15844049 0.89 TTK (0.67) TTK
SCHEMBL9975228 0.87 TTK (0.67) TTK
SCHEMBL15844025 0.86 TTK (0.68) TTK
SCHEMBL9938682 0.85 TTK (0.76) TTK
SCHEMBL9943239 0.85 TTK (0.67) TTK
SCHEMBL9942711 0.85 TTK (0.66) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651950-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080230-A1 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed